|
Insider Trading: Biogen Idec Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biogen Idec Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Biogen Idec Inc since year 2005. Table 2 shows the detailed insider transactions of Biogen Idec Inc since 2005.
The reporting company's ticker symbol is BIIB.
The reporting company's CIK number is 875045.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $270,161,810.
The total value of stock exercises is $161,639,742.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Biogen Idec Inc (BIIB) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Figure 2. Average prices of insider buys, sales, and option exercises at Biogen Idec Inc (BIIB) in the past 24 months. See table 2 for insider transaction details.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Biogen Idec Inc (BIIB).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-10 | 0 | 0 | 2,047 | 102,350 | 0 | 0 |
| 2008-09 | 0 | 0 | 2,287 | 114,350 | 0 | 0 |
| 2008-08 | 0 | 0 | 568 | 28,777 | 0 | 0 |
| 2008-07 | 0 | 0 | 343,119 | 23,401,098 | 294,409 | 41,408,916 |
| 2008-06 | 0 | 0 | 1,840 | 113,384 | 0 | 0 |
| 2008-04 | 0 | 0 | 1,615,272 | 104,386,631 | 915,844 | 37,296,979 |
| 2008-02 | 0 | 0 | 75,110 | 4,591,969 | 100,385 | 1,392,918 |
| 2008-01 | 0 | 0 | 0 | 0 | 3,333 | 0 |
| 2007-12 | 0 | 0 | 69,569 | 3,974,085 | 43,119 | 1,875,676 |
| 2007-11 | 0 | 0 | 0 | 0 | 1,000 | 0 |
| 2007-10 | 0 | 0 | 350,995 | 28,781,590 | 350,995 | 20,143,358 |
| 2007-09 | 0 | 0 | 66,639 | 4,331,535 | 66,639 | 3,820,633 |
| 2007-08 | 0 | 0 | 146,231 | 9,219,898 | 146,231 | 6,821,052 |
| 2007-07 | 0 | 0 | 449,290 | 25,508,602 | 448,557 | 19,025,836 |
| 2007-06 | 0 | 0 | 33,102 | 1,745,642 | 27,277 | 1,070,562 |
| 2007-05 | 0 | 0 | 50,815 | 2,549,095 | 55,619 | 1,449,400 |
| 2007-04 | 0 | 0 | 78,747 | 3,749,464 | 63,737 | 2,370,547 |
| 2007-03 | 0 | 0 | 46,084 | 2,047,627 | 5,000 | 176,850 |
| 2007-02 | 0 | 0 | 75,498 | 3,720,488 | 89,105 | 176,850 |
| 2007-01 | 0 | 0 | 31,176 | 1,584,010 | 33,157 | 358,498 |
| 2006-11 | 0 | 0 | 497,800 | 25,087,889 | 497,800 | 17,775,788 |
| 2006-10 | 0 | 0 | 77,488 | 3,521,561 | 66,244 | 874,622 |
| 2006-09 | 0 | 0 | 113,791 | 4,878,768 | 6,900 | 104,604 |
| 2006-07 | 0 | 0 | 109,000 | 4,543,252 | 109,000 | 1,354,792 |
| 2006-05 | 0 | 0 | 0 | 0 | 1,250 | 0 |
| 2006-04 | 0 | 0 | 58,675 | 2,650,851 | 58,675 | 588,361 |
| 2006-03 | 0 | 0 | 10,350 | 485,966 | 10,350 | 156,906 |
| 2006-01 | 0 | 0 | 118,420 | 5,230,413 | 103,500 | 3,050,145 |
| 2005-12 | 0 | 0 | 20,500 | 914,915 | 20,500 | 346,449 |
| 2005-07 | 0 | 0 | 80,000 | 2,897,600 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Biogen Idec Inc (BIIB)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-10-06 | Maclean Michael F (SVP, Chief Accounting Officer) | Sale | 2,047 | 50.00 | 102,350 |
| 2008-09-26 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 734 | 50.00 | 36,700 |
| 2008-09-19 | Clancy Paul J (Executive VP and CFO) | Sale | 1,553 | 50.00 | 77,650 |
| 2008-08-08 | Clancy Paul J (Executive VP and CFO) | Sale | 568 | 50.66 | 28,777 |
| 2008-07-31 | Maclean Michael F (SVP, Chief Accounting Officer) | Sale | 1,875 | 72.77 | 136,443 |
| 2008-07-31 | Maclean Michael F (SVP, Chief Accounting Officer) | Option Exercise | 1,875 | 47.77 | 89,568 |
| 2008-07-25 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 1,603 | 35.37 | 56,698 |
| 2008-07-23 | Pickett Cecil B (President, R & D) | Sale | 5,054 | 72.00 | 363,888 |
| 2008-07-22 | Maclean Michael F (SVP, Chief Accounting Officer) | Sale | 682 | 70.00 | 47,740 |
| 2008-07-22 | Hamm Robert A (EVP, Pharma. Oper. & Tech.) | Sale | 156,086 | 70.00 | 10,926,020 |
| 2008-07-22 | Hamm Robert A (EVP, Pharma. Oper. & Tech.) | Option Exercise | 156,086 | 49.86 | 7,781,667 |
| 2008-07-22 | Alexander Susan H (EVP, General Counsel) | Sale | 2,000 | 70.00 | 140,000 |
| 2008-07-22 | Dunn John Michael (EVP, New Ventures) | Sale | 6,485 | 71.50 | 463,677 |
| 2008-07-22 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 6,485 | 43.50 | 282,097 |
| 2008-07-22 | Pickett Cecil B (President, R & D) | Sale | 23,108 | 70.00 | 1,617,560 |
| 2008-07-22 | Hasler Hans Peter (EVP, Global Neurology, Int'l) | Sale | 12,950 | 69.31 | 897,564 |
| 2008-07-22 | Hasler Hans Peter (EVP, Global Neurology, Int'l) | Option Exercise | 12,950 | 49.31 | 638,564 |
| 2008-07-21 | Dunn John Michael (EVP, New Ventures) | Sale | 6,485 | 67.50 | 437,737 |
| 2008-07-21 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 6,485 | 4,350.00 | 28,209,750 |
| 2008-07-21 | Sharp Philip A (Director) | Sale | 72,500 | 68.00 | 4,930,000 |
| 2008-07-21 | Sharp Philip A (Director) | Option Exercise | 72,500 | 35.42 | 2,567,950 |
| 2008-07-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 6,250 | 64.00 | 400,000 |
| 2008-07-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 6,250 | 59.39 | 371,187 |
| 2008-07-09 | Hasnain Faheem (EVP, Oncology/Rheumatology SBU) | Sale | 36,837 | 62.13 | 2,288,850 |
| 2008-07-09 | Hasnain Faheem (EVP, Oncology/Rheumatology SBU) | Option Exercise | 30,175 | 46.78 | 1,411,435 |
| 2008-07-08 | Alexander Susan H (EVP, General Counsel) | Sale | 8,599 | 60.00 | 515,940 |
| 2008-07-01 | Clancy Paul J (CFO) | Sale | 4,208 | 56.01 | 235,679 |
| 2008-06-04 | Ross Bruce (Director) | Sale | 1,840 | 61.62 | 113,384 |
| 2008-04-29 | Glassberg Alan (Director) | Sale | 10,000 | 61.63 | 616,342 |
| 2008-04-29 | Glassberg Alan (Director) | Option Exercise | 10,000 | 31.08 | 310,833 |
| 2008-04-15 | Hamm Robert A (EVP, Pharma. Oper. & Tech.) | Sale | 3,413 | 63.82 | 217,807 |
| 2008-04-15 | Mullen James C (CEO & President) | Sale | 12,800 | 64.95 | 831,360 |
| 2008-04-15 | Mullen James C (CEO & President) | Option Exercise | 12,800 | 44.59 | 570,752 |
| 2008-04-14 | Dunn John Michael (EVP, New Ventures) | Sale | 3,212 | 64.19 | 206,186 |
| 2008-04-14 | Mullen James C (CEO & President) | Sale | 200 | 64.95 | 12,990 |
| 2008-04-14 | Mullen James C (CEO & President) | Option Exercise | 200 | 44.59 | 8,918 |
| 2008-04-11 | Mullen James C (CEO & President) | Sale | 745,750 | 64.87 | 48,299,667 |
| 2008-04-11 | Mullen James C (CEO & President) | Option Exercise | 745,750 | 42.75 | 31,880,812 |
| 2008-04-08 | Maclean Michael F (SVP, Chief Accounting Officer) | Sale | 2,214 | 64.39 | 142,553 |
| 2008-04-08 | Hasnain Faheem (EVP, Oncology/Rheumatology SBU) | Sale | 6,425 | 64.47 | 414,188 |
| 2008-04-08 | Pangia Robert W (Director) | Sale | 30,000 | 64.47 | 1,931,923 |
| 2008-04-08 | Pangia Robert W (Director) | Option Exercise | 30,000 | 7.79 | 233,751 |
| 2008-04-08 | Sharp Philip A (Director) | Sale | 100,000 | 64.47 | 6,431,598 |
| 2008-04-08 | Sharp Philip A (Director) | Option Exercise | 100,000 | 35.42 | 3,542,000 |
| 2008-04-08 | Hasler Hans Peter (EVP, Global Neurology, Int'l) | Sale | 28,493 | 64.34 | 1,831,310 |
| 2008-04-08 | Hasler Hans Peter (EVP, Global Neurology, Int'l) | Option Exercise | 17,094 | 43.87 | 749,913 |
| 2008-02-21 | Clancy Paul J (CFO) | Sale | 2,183 | 60.29 | 131,621 |
| 2008-02-19 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Sale | 3,344 | 63.18 | 211,285 |
| 2008-02-15 | Alexander Susan H (EVP, General Counsel) | Option Exercise | 2,667 | .00 | 0 |
| 2008-02-12 | Clancy Paul J (CFO) | Sale | 958 | 60.99 | 58,428 |
| 2008-02-12 | Hamm Robert A (EVP, Pharma. Oper. & Tech.) | Sale | 3,679 | 60.91 | 224,080 |
| 2008-02-12 | Dunn John Michael (EVP, New Ventures) | Sale | 2,267 | 60.94 | 138,147 |
| 2008-02-12 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 4,286 | 60.95 | 261,226 |
| 2008-02-12 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Sale | 15,134 | 61.00 | 922,644 |
| 2008-02-12 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Option Exercise | 9,725 | 49.31 | 479,539 |
| 2008-02-07 | Mullen James C (CEO & President) | Option Exercise | 26,667 | .00 | 0 |
| 2008-02-06 | Hasnain Faheem (EVP, Oncology/Rheumatology SBU) | Option Exercise | 5,467 | .00 | 0 |
| 2008-02-06 | Hamm Robert A (EVP, Pharma. Oper. & Tech.) | Option Exercise | 5,467 | .00 | 0 |
| 2008-02-06 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 3,633 | .00 | 0 |
| 2008-02-06 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 11,925 | 61.17 | 729,425 |
| 2008-02-06 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 18,292 | 22.12 | 404,619 |
| 2008-02-06 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Sale | 15,000 | 61.25 | 917,243 |
| 2008-02-06 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Option Exercise | 23,000 | 22.12 | 508,760 |
| 2008-02-06 | Hasler Hans Peter (EVP, Global Neurology, Int'l) | Option Exercise | 5,467 | .00 | 0 |
| 2008-01-30 | Alexander Susan H (EVP, General Counsel) | Option Exercise | 3,333 | .00 | 0 |
| 2007-12-31 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 6,869 | 57.21 | 392,999 |
| 2007-12-31 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 6,869 | 43.50 | 298,801 |
| 2007-12-31 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Sale | 36,250 | 57.21 | 2,071,509 |
| 2007-12-31 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Option Exercise | 36,250 | 43.50 | 1,576,875 |
| 2007-11-01 | Maclean Michael F (SVP, Chief Accounting Officer) | Option Exercise | 1,000 | .00 | 0 |
| 2007-10-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 89,645 | 82.00 | 7,350,890 |
| 2007-10-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 89,645 | 66.32 | 5,944,808 |
| 2007-10-15 | Schenk Lynn (Director) | Sale | 63,000 | 82.00 | 5,166,000 |
| 2007-10-15 | Schenk Lynn (Director) | Option Exercise | 63,000 | 37.48 | 2,361,134 |
| 2007-10-15 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Sale | 18,750 | 82.00 | 1,537,500 |
| 2007-10-15 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Option Exercise | 18,750 | 67.57 | 1,266,937 |
| 2007-10-15 | Hasler Hans Peter (SVP, International) | Sale | 108,750 | 82.00 | 8,917,500 |
| 2007-10-15 | Hasler Hans Peter (SVP, International) | Option Exercise | 108,750 | 58.53 | 6,365,137 |
| 2007-10-15 | Adelman Burt A (EVP, Portfolio Strategy) | Sale | 60,500 | 82.00 | 4,961,000 |
| 2007-10-15 | Adelman Burt A (EVP, Portfolio Strategy) | Option Exercise | 60,500 | 64.92 | 3,927,962 |
| 2007-10-15 | Keller Thomas F (Director) | Sale | 10,350 | 82.00 | 848,700 |
| 2007-10-15 | Keller Thomas F (Director) | Option Exercise | 10,350 | 26.80 | 277,380 |
| 2007-09-06 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 66,639 | 65.00 | 4,331,535 |
| 2007-09-06 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 66,639 | 57.33 | 3,820,633 |
| 2007-08-30 | Hasler Hans Peter (SVP, International) | Sale | 10,225 | 64.24 | 656,854 |
| 2007-08-30 | Hasler Hans Peter (SVP, International) | Option Exercise | 10,225 | 44.24 | 452,354 |
| 2007-08-30 | Adelman Burt A (EVP, Portfolio Strategy) | Sale | 46,000 | 64.03 | 2,945,380 |
| 2007-08-30 | Adelman Burt A (EVP, Portfolio Strategy) | Option Exercise | 46,000 | 49.03 | 2,255,380 |
| 2007-08-27 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 18,750 | 64.00 | 1,200,000 |
| 2007-08-27 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 18,750 | 59.39 | 1,113,562 |
| 2007-08-27 | Hasler Hans Peter (SVP, International) | Sale | 20,606 | 63.50 | 1,308,481 |
| 2007-08-27 | Hasler Hans Peter (SVP, International) | Option Exercise | 20,606 | 43.50 | 896,361 |
| 2007-08-27 | Adelman Burt A (EVP, Portfolio Strategy) | Sale | 8,750 | 63.50 | 555,625 |
| 2007-08-27 | Adelman Burt A (EVP, Portfolio Strategy) | Option Exercise | 8,750 | 43.50 | 380,625 |
| 2007-08-24 | Ross Bruce (Director) | Sale | 6,250 | 62.00 | 387,500 |
| 2007-08-24 | Ross Bruce (Director) | Option Exercise | 6,250 | 36.94 | 230,875 |
| 2007-08-24 | Keller Thomas F (Director) | Sale | 6,900 | 62.00 | 427,800 |
| 2007-08-24 | Keller Thomas F (Director) | Option Exercise | 6,900 | 26.80 | 184,920 |
| 2007-08-17 | Adelman Burt A (EVP, Portfolio Strategy) | Sale | 28,750 | 60.46 | 1,738,258 |
| 2007-08-17 | Adelman Burt A (EVP, Portfolio Strategy) | Option Exercise | 28,750 | 45.46 | 1,306,975 |
| 2007-07-26 | Adelman Burt A (EVP, Portfolio Strategy) | Sale | 115,000 | 59.61 | 6,855,150 |
| 2007-07-26 | Adelman Burt A (EVP, Portfolio Strategy) | Option Exercise | 115,000 | 49.61 | 5,705,150 |
| 2007-07-25 | Kowolenko Michael (SVP, Pharm Ops & Technology) | Sale | 20,507 | 58.00 | 1,189,406 |
| 2007-07-25 | Kowolenko Michael (SVP, Pharm Ops & Technology) | Option Exercise | 20,507 | 41.83 | 857,756 |
| 2007-07-25 | Dunn John Michael (EVP, New Ventures) | Sale | 20,000 | 57.75 | 1,155,000 |
| 2007-07-25 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 20,000 | 43.50 | 870,000 |
| 2007-07-25 | Ross Bruce (Director) | Sale | 5,000 | 58.00 | 290,000 |
| 2007-07-25 | Ross Bruce (Director) | Option Exercise | 5,000 | 34.34 | 171,700 |
| 2007-07-25 | Hasler Hans Peter (SVP, International) | Sale | 34,500 | 57.45 | 1,982,025 |
| 2007-07-25 | Hasler Hans Peter (SVP, International) | Option Exercise | 34,500 | 37.45 | 1,292,025 |
| 2007-07-25 | Adelman Burt A (EVP, Portfolio Strategy) | Sale | 29,000 | 57.98 | 1,681,275 |
| 2007-07-25 | Adelman Burt A (EVP, Portfolio Strategy) | Option Exercise | 29,000 | 40.48 | 1,173,775 |
| 2007-07-24 | Ross Bruce (Director) | Sale | 5,000 | 56.00 | 280,000 |
| 2007-07-24 | Ross Bruce (Director) | Option Exercise | 5,000 | 34.34 | 171,700 |
| 2007-07-12 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 41,128 | 55.00 | 2,262,040 |
| 2007-07-12 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 41,128 | 35.21 | 1,448,046 |
| 2007-07-12 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Sale | 124,057 | 54.90 | 6,810,729 |
| 2007-07-12 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Option Exercise | 124,057 | 41.73 | 5,176,898 |
| 2007-07-09 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Sale | 28,443 | 54.90 | 1,561,520 |
| 2007-07-09 | Schneier Craig Eric (EVP, HR, Public Affairs & Comm) | Option Exercise | 28,443 | 40.48 | 1,151,230 |
| 2007-07-03 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 15,697 | 54.00 | 847,638 |
| 2007-07-03 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 15,697 | 35.37 | 555,202 |
| 2007-07-03 | Adelman Burt A (EVP, Portfolio Strategy) | Sale | 10,225 | 54.24 | 554,604 |
| 2007-07-03 | Adelman Burt A (EVP, Portfolio Strategy) | Option Exercise | 10,225 | 44.24 | 452,354 |
| 2007-07-02 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 733 | 53.50 | 39,215 |
| 2007-06-27 | Dunn John Michael (EVP, New Ventures) | Sale | 15,352 | 52.90 | 812,120 |
| 2007-06-27 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 15,352 | 35.37 | 543,000 |
| 2007-06-27 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 11,925 | 53.00 | 632,076 |
| 2007-06-27 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 11,925 | 44.24 | 527,562 |
| 2007-06-20 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 5,825 | 51.75 | 301,446 |
| 2007-05-31 | Ross Bruce (Director) | Sale | 1,500 | 51.91 | 77,865 |
| 2007-05-30 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 6,869 | 51.54 | 354,028 |
| 2007-05-30 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 6,869 | 43.50 | 298,801 |
| 2007-05-30 | Glassberg Alan (Director) | Sale | 20,000 | 51.54 | 1,030,800 |
| 2007-05-30 | Glassberg Alan (Director) | Option Exercise | 20,000 | 31.08 | 621,666 |
| 2007-05-25 | Young William (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-25 | Schenk Lynn (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-25 | Ross Bruce (Director) | Option Exercise | 3,750 | .00 | 0 |
| 2007-05-25 | Glassberg Alan (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-25 | Sharp Philip A (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-25 | Good Mary L (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-25 | Belzer Alan (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-25 | Best Lawrence C (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-25 | Keller Thomas F (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2007-05-23 | Hasnain Faheem (SVP, Oncology SBU) | Sale | 7,446 | 49.00 | 364,854 |
| 2007-05-23 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 10,000 | 49.00 | 490,000 |
| 2007-05-23 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 10,000 | 35.21 | 352,083 |
| 2007-05-16 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 5,000 | 46.31 | 231,548 |
| 2007-05-16 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 5,000 | 35.37 | 176,850 |
| 2007-04-23 | Hamm Robert A (SVP, Neurology SBU) | Sale | 3,731 | 47.34 | 176,632 |
| 2007-04-23 | Dunn John Michael (EVP, New Ventures) | Sale | 18,760 | 48.90 | 917,364 |
| 2007-04-23 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 15,000 | 35.37 | 530,550 |
| 2007-04-23 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 43,737 | 47.59 | 2,081,601 |
| 2007-04-23 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 43,737 | 38.03 | 1,663,147 |
| 2007-04-20 | Dunn John Michael (EVP, New Ventures) | Sale | 7,519 | 46.02 | 346,017 |
| 2007-04-16 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 5,000 | 45.57 | 227,850 |
| 2007-04-16 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 5,000 | 35.37 | 176,850 |
| 2007-03-20 | Kowolenko Michael (SVP, Pharm Ops & Technology) | Sale | 3,756 | 44.48 | 167,062 |
| 2007-03-20 | Hamm Robert A (SVP, Immunology Business Unit) | Sale | 5,077 | 44.48 | 225,819 |
| 2007-03-20 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 5,929 | 44.48 | 263,715 |
| 2007-03-20 | Schneier Craig Eric (EVP, Human Resources) | Sale | 6,526 | 44.48 | 290,269 |
| 2007-03-20 | Kellogg Peter N (EVP, Finance and CFO) | Sale | 7,252 | 44.48 | 322,560 |
| 2007-03-20 | Hasler Hans Peter (SVP, International) | Sale | 5,910 | 44.48 | 262,870 |
| 2007-03-20 | Adelman Burt A (EVP, Development) | Sale | 6,634 | 44.48 | 295,073 |
| 2007-03-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 5,000 | 44.05 | 220,259 |
| 2007-03-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 5,000 | 35.37 | 176,850 |
| 2007-02-15 | Alexander Susan H (EVP, General Counsel) | Option Exercise | 2,667 | .00 | 0 |
| 2007-02-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 5,000 | 50.17 | 250,862 |
| 2007-02-15 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 5,000 | 35.37 | 176,850 |
| 2007-02-13 | Kowolenko Michael (SVP, Pharm Ops & Technology) | Sale | 8,828 | 49.22 | 434,478 |
| 2007-02-13 | Hamm Robert A (SVP, Immunology Business Unit) | Sale | 6,188 | 49.22 | 304,548 |
| 2007-02-13 | Dunn John Michael (EVP, New Ventures) | Sale | 2,334 | 49.22 | 114,870 |
| 2007-02-13 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 10,595 | 49.22 | 521,443 |
| 2007-02-13 | Schneier Craig Eric (EVP, Human Resources) | Sale | 15,290 | 49.22 | 752,512 |
| 2007-02-13 | Kellogg Peter N (EVP, Finance and CFO) | Sale | 10,202 | 49.22 | 502,101 |
| 2007-02-13 | Hasler Hans Peter (SVP, International) | Sale | 5,190 | 49.22 | 255,431 |
| 2007-02-13 | Adelman Burt A (EVP, Development) | Sale | 11,871 | 49.22 | 584,243 |
| 2007-02-07 | Mullen James C (CEO & President) | Option Exercise | 26,667 | .00 | 0 |
| 2007-02-06 | Hasnain Faheem (SVP, Oncology SBU) | Option Exercise | 5,467 | .00 | 0 |
| 2007-02-06 | Kowolenko Michael (SVP, Pharm Ops & Technology) | Option Exercise | 4,534 | .00 | 0 |
| 2007-02-06 | Hamm Robert A (SVP, Immunology Business Unit) | Option Exercise | 5,467 | .00 | 0 |
| 2007-02-06 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 3,634 | .00 | 0 |
| 2007-02-06 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 6,367 | .00 | 0 |
| 2007-02-06 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Option Exercise | 1,834 | .00 | 0 |
| 2007-02-06 | Schneier Craig Eric (EVP, Human Resources) | Option Exercise | 8,000 | .00 | 0 |
| 2007-02-06 | Kellogg Peter N (EVP, Finance and CFO) | Option Exercise | 8,534 | .00 | 0 |
| 2007-02-06 | Hasler Hans Peter (SVP, International) | Option Exercise | 5,467 | .00 | 0 |
| 2007-02-06 | Adelman Burt A (EVP, Development) | Option Exercise | 5,467 | .00 | 0 |
| 2007-01-30 | Alexander Susan H (EVP, General Counsel) | Option Exercise | 3,334 | .00 | 0 |
| 2007-01-16 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 6,353 | 50.73 | 322,315 |
| 2007-01-16 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Option Exercise | 5,000 | 35.37 | 176,850 |
| 2007-01-16 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Sale | 24,823 | 50.83 | 1,261,695 |
| 2007-01-16 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Option Exercise | 24,823 | 7.32 | 181,648 |
| 2006-11-27 | Mullen James C (CEO & President) | Sale | 12,500 | 50.99 | 637,336 |
| 2006-11-27 | Mullen James C (CEO & President) | Option Exercise | 12,500 | 36.09 | 451,125 |
| 2006-11-22 | Ross Bruce (Director) | Sale | 7,500 | 52.00 | 390,000 |
| 2006-11-22 | Ross Bruce (Director) | Option Exercise | 7,500 | 31.08 | 233,124 |
| 2006-11-20 | Mullen James C (CEO & President) | Sale | 159,000 | 51.25 | 8,148,580 |
| 2006-11-20 | Mullen James C (CEO & President) | Option Exercise | 159,000 | 36.09 | 5,738,310 |
| 2006-11-17 | Ross Bruce (Director) | Sale | 7,500 | 50.00 | 375,000 |
| 2006-11-17 | Ross Bruce (Director) | Option Exercise | 7,500 | 31.08 | 233,124 |
| 2006-11-17 | Mullen James C (CEO & President) | Sale | 70,123 | 49.95 | 3,502,643 |
| 2006-11-17 | Mullen James C (CEO & President) | Option Exercise | 70,123 | 36.09 | 2,530,739 |
| 2006-11-16 | Mullen James C (CEO & President) | Sale | 229,877 | 49.96 | 11,484,080 |
| 2006-11-16 | Mullen James C (CEO & President) | Option Exercise | 229,877 | 35.76 | 8,219,252 |
| 2006-11-15 | Dunn John Michael (EVP, New Ventures) | Sale | 7,850 | 49.00 | 384,650 |
| 2006-11-15 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 7,850 | 35.37 | 277,654 |
| 2006-11-01 | Keller Thomas F (Director) | Sale | 3,450 | 48.00 | 165,600 |
| 2006-11-01 | Keller Thomas F (Director) | Option Exercise | 3,450 | 26.80 | 92,460 |
| 2006-10-31 | Dunn John Michael (EVP, New Ventures) | Sale | 13,104 | 46.79 | 613,170 |
| 2006-10-31 | Dunn John Michael (EVP, New Ventures) | Option Exercise | 13,104 | 35.37 | 463,488 |
| 2006-10-16 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Sale | 40,000 | 45.51 | 1,820,573 |
| 2006-10-16 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Option Exercise | 40,000 | 7.72 | 308,752 |
| 2006-10-02 | Hasnain Faheem (SVP, Oncology SBU) | Sale | 11,244 | 44.61 | 501,617 |
| 2006-10-02 | Glassberg Alan (Director) | Sale | 13,140 | 44.61 | 586,201 |
| 2006-10-02 | Glassberg Alan (Director) | Option Exercise | 13,140 | 7.79 | 102,382 |
| 2006-09-19 | Kowolenko Michael (SVP, Pharm Ops & Technology) | Sale | 11,942 | 42.76 | 510,681 |
| 2006-09-19 | Hamm Robert A (SVP, Immunology Business Unit) | Sale | 16,207 | 42.76 | 693,067 |
| 2006-09-19 | Wiggins Mark C (EVP Corp. and Bus. Dev.) | Sale | 18,186 | 42.76 | 777,696 |
| 2006-09-19 | Schneier Craig Eric (EVP, Human Resources) | Sale | 20,175 | 42.76 | 862,753 |
| 2006-09-19 | Kellogg Peter N (EVP, Finance and CFO) | Sale | 22,033 | 42.76 | 942,207 |
| 2006-09-19 | Adelman Burt A (EVP, Development) | Sale | 18,348 | 42.76 | 784,624 |
| 2006-09-01 | Keller Thomas F (Director) | Sale | 6,900 | 44.60 | 307,740 |
| 2006-09-01 | Keller Thomas F (Director) | Option Exercise | 6,900 | 15.16 | 104,604 |
| 2006-07-26 | Belzer Alan (Director) | Sale | 29,000 | 41.00 | 1,188,951 |
| 2006-07-26 | Belzer Alan (Director) | Option Exercise | 29,000 | 15.16 | 439,640 |
| 2006-07-25 | Belzer Alan (Director) | Sale | 20,000 | 41.55 | 831,000 |
| 2006-07-25 | Belzer Alan (Director) | Option Exercise | 20,000 | 15.16 | 303,200 |
| 2006-07-24 | Belzer Alan (Director) | Sale | 20,000 | 40.81 | 816,271 |
| 2006-07-24 | Belzer Alan (Director) | Option Exercise | 20,000 | 15.16 | 303,200 |
| 2006-07-17 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Sale | 40,000 | 42.68 | 1,707,030 |
| 2006-07-17 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Option Exercise | 40,000 | 7.72 | 308,752 |
| 2006-05-25 | Pangia Robert W (Director) | Option Exercise | 1,250 | .00 | 0 |
| 2006-04-28 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Sale | 40,000 | 45.17 | 1,806,720 |
| 2006-04-28 | Matsui Connie (EVP, Corp. Strategy and Comm.) | Option Exercise | 40,000 | 7.72 | 308,752 |
| 2006-04-28 | Good Mary L (Director) | Sale | 10,000 | 45.23 | 452,299 |
| 2006-04-28 | Good Mary L (Director) | Option Exercise | 10,000 | 14.48 | 144,800 |
| 2006-04-28 | Mullen James C (CEO & President) | Sale | 8,675 | 45.17 | 391,832 |
| 2006-04-28 | Mullen James C (CEO & President) | Option Exercise | 8,675 | 15.54 | 134,809 |
| 2006-03-31 | Keller Thomas F (Director) | Sale | 10,350 | 46.95 | 485,966 |
| 2006-03-31 | Keller Thomas F (Director) | Option Exercise | 10,350 | 15.16 | 156,906 |
| 2006-01-03 | Wiggins Mark C (EVP - Business Devel) | Sale | 14,920 | 35.21 | 525,303 |
| 2006-01-03 | Adelman Burt A (EVP, Development) | Sale | 103,500 | 45.46 | 4,705,110 |
| 2006-01-03 | Adelman Burt A (EVP, Development) | Option Exercise | 103,500 | 29.47 | 3,050,145 |
| 2005-12-28 | Adelman Burt A (EVP, Development) | Sale | 20,500 | 44.63 | 914,915 |
| 2005-12-28 | Adelman Burt A (EVP, Development) | Option Exercise | 20,500 | 16.90 | 346,449 |
| 2005-07-12 | Matsui Connie (EVP, Corp. Strategy) | Sale | 80,000 | 36.22 | 2,897,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Biogen Idec Inc (symbol BIIB,
CIK number 875045) see
the Securities and Exchange Commission (SEC) website.
|
|
